Caxton Associates (New York)’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,290
Closed -$775K 558
2023
Q4
$775K Sell
5,290
-5,880
-53% -$871K 0.04% 261
2023
Q3
$1.63M Sell
11,170
-2,689
-19% -$411K 0.22% 76
2023
Q2
$2.1M Buy
13,859
+6,286
+83% +$947K 0.31% 65
2023
Q1
$1.13M Buy
7,573
+2,486
+49% +$355K 0.17% 122
2022
Q4
$771K Buy
+5,087
New +$713K 0.05% 161
2022
Q3
Sell
-5,404
Closed -$777K 625
2022
Q2
$777K Sell
5,404
-4,581
-46% -$689K 0.08% 179
2022
Q1
$1.53M Buy
+9,985
New +$1.56M 0.12% 52
2019
Q2
Sell
-84,648
Closed -$8.81M 498
2019
Q1
$8.81M Hold
84,648
1.28% 20
2018
Q4
$7.78M Buy
+84,648
New +$7.57M 1.23% 12
2018
Q2
Sell
-19,048
Closed -$1.43M 457
2018
Q1
$1.51M Buy
+19,048
New +$1.59M 0.08% 146
2017
Q4
Sell
-8,300
Closed -$755K 488
2017
Q3
$755K Sell
8,300
-100
-1% -$9.1K 0.03% 232
2017
Q2
$732K Sell
8,400
-14,200
-63% -$1.25M 0.03% 218
2017
Q1
$2.03M Buy
+22,600
New +$2M 0.01% 174
2016
Q4
Sell
-30,000
Closed -$2.69M 254
2016
Q3
$2.69M Buy
+30,000
New +$2.61M 0.09% 139

Other funds holding PG

Caxton Associates (New York)'s PG Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Procter & Gamble (PG) in Q1 2024, closing a stake of 5,290 shares — an estimated $775K sold.

Caxton Associates (New York) first reported a position in PG in Q3 2016 and held it in 14 quarters. The position peaked at $8.81M in Q1 2019. 3,648 funds tracked by Wall St. Rank hold PG as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Procter & Gamble position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 5,290 Procter & Gamble shares in Q1 2024, an estimated $775K.
  • Caxton Associates (New York) first reported a position in Procter & Gamble in Q3 2016 and held it in 14 quarters.
  • Caxton Associates (New York)'s Procter & Gamble position peaked at $8.81M in Q1 2019.
  • 3,648 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.